Browsing publications by Dr Julie Irving

Newcastle AuthorsTitleYearFull text
Professor Anthony Moorman
Dr Julie Irving
Professor James Allan
Professor Christine Harrison
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.12017
Zach Dixon
Dr Lindsay Nicholson
Elizabeth Matheson
Dr Paul Sinclair
Professor Christine Harrison
et al.
CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response2017
Dr Julie Irving
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia2017
Judith Weiland
Dr Deepali Pal
Marian Case
Dr Julie Irving
Dr Frida Ponthan
et al.
BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance2016
Dr Julie Irving
Dr Amir Enshaei
Dr Amy Erhorn
Lynne Minto
Claire Schwab
et al.
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukaemia2016
Rosanna Jackson
Dr Julie Irving
Dr Gareth Veal
Personalisation of dexamethasone therapy in childhood acute lymphoblastic leukaemia2016
Dr Alex Elder
Dr Klaus Rehe
Dr Simon Bomken
Dr Paul Sinclair
Katie Dormon
et al.
The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.2016
Dr Sarra Ryan
Elizabeth Matheson
Dr Paul Sinclair
Dr Matthew Bashton
Claire Schwab
et al.
The role of the RAS pathway in iAMP21-ALL2016
Dr Julie Irving
Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia2016
Dr Julie Irving
Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL2016
123456789101112